diabetes is associated with a fall in serum insulin-like growth factor-i ( igf-1 ) and a rise in somatomedin inhibitor , a circulating factor ( s ) of approximately 30,000 mw that is released by the liver and can antagonize both somatomedin and insulin action .
C0021665
igf-1
C0037657
somatomedin